Intuitive Surgical (ISRG) Net Cash Flow Growth (3y) (2012 - 2026)
Powered by 
Analysis
Intuitive Surgical (ISRG) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | -9.45% |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | -16.59% |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | -0.80% |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | 60.16% |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | -85.83% |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | 43.26% |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | -26.30% |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | -339.28% |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | 1.60% |
| 10 | Steris | 20.01 Bn | 19.54 Bn | 684.20 Mn | 269.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.59% |
| Mar 31, 2026 | -63.96% |
| Dec 31, 2025 | 123.00% |
| Sep 30, 2025 | -774.94% |
| Jun 30, 2025 | 24.35% |
| Mar 31, 2025 | 70.07% |
| Dec 31, 2024 | -92.83% |
| Sep 30, 2024 | -31.24% |
| Jun 30, 2024 | -2.03% |
| Mar 31, 2024 | 34.02% |
| Dec 31, 2023 | -74.83% |
| Sep 30, 2023 | 30.95% |
| Jun 30, 2023 | 16.48% |
| Mar 31, 2023 | 114.60% |
| Dec 31, 2022 | -37.06% |
| Sep 30, 2022 | -82.93% |
| Jun 30, 2022 | 91.75% |
| Mar 31, 2022 | -122.05% |
| Dec 31, 2021 | 21.83% |
| Sep 30, 2021 | -11.31% |